Aspire Private Capital’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8
Closed -$181 172
2024
Q3
$181 Hold
8
﹤0.01% 643
2024
Q2
$198 Hold
8
﹤0.01% 655
2024
Q1
$263 Hold
8
﹤0.01% 677
2023
Q4
$290 Hold
8
﹤0.01% 662
2023
Q3
$293 Hold
8
﹤0.01% 661
2023
Q2
$307 Hold
8
﹤0.01% 627
2023
Q1
$328 Hold
8
﹤0.01% 614
2022
Q4
$278 Hold
8
﹤0.01% 616
2022
Q3
$0 Hold
8
﹤0.01% 604
2022
Q2
$0 Hold
8
﹤0.01% 598
2022
Q1
$0 Hold
8
﹤0.01% 595
2021
Q4
$0 Hold
8
﹤0.01% 630
2021
Q3
$0 Hold
8
﹤0.01% 586
2021
Q2
$0 Hold
8
﹤0.01% 577
2021
Q1
$0 Hold
8
﹤0.01% 530
2020
Q4
$0 Buy
+8
New +$226 ﹤0.01% 457
2020
Q1
Sell
-8
Closed 232
2019
Q4
$0 Hold
8
﹤0.01% 484
2019
Q3
$0 Hold
8
﹤0.01% 458
2019
Q2
$0 Hold
8
﹤0.01% 520
2019
Q1
$0 Hold
8
﹤0.01% 551
2018
Q4
$0 Buy
+8
New +$207 ﹤0.01% 529

Other funds holding ADNT

Aspire Private Capital's ADNT Position: Q4 2024 in Review

Aspire Private Capital sold out of Adient (ADNT) in Q4 2024, closing a stake of 8 shares — an estimated $181 sold.

Aspire Private Capital first reported a position in ADNT in Q4 2018 and held it in 21 quarters. The position peaked at $328 in Q1 2023. 270 funds tracked by Wall St. Rank hold ADNT as of Q4 2024.

  • Aspire Private Capital reported no remaining Adient position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 8 Adient shares in Q4 2024, an estimated $181.
  • Aspire Private Capital first reported a position in Adient in Q4 2018 and held it in 21 quarters.
  • Aspire Private Capital's Adient position peaked at $328 in Q1 2023.
  • 270 funds tracked by Wall St. Rank held Adient as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.